The binding of [I-125] orexin-A (Ox-A) to particulates from Chinese hamster
ovary (CHO) cells expressing the cloned orexin-A receptor, or from rat for
ebrain areas, was sensitive to blockers of phosphatidylinositol-specific ph
ospholipase C (PtdIns-PLC) U-73122 and ET-18-OCH3, little affected by phosp
holipase A(2) inhibitor quinacrine, and not sensitive to D609, a xanthate i
nhibitor of phosphatidylcholine-selective PLC. Interaction of the receptor
with a PtdIns-PLC was further indicated by a large sensitivity of the bindi
ng to Ca2+. Up to 50% of the binding was sensitive to the G-protein nucleot
ide site agonist GTP-gamma-S. Ligand attachment to the orexin-A receptor th
us depends on an association with both PtdIns-PLC and G-protein alpha-subun
its. In all paradigms examined, the binding of [I-125]orexin-A was competed
by human/rat neuropeptide Y (hNPY) and porcine secretin with a potency sim
ilar to orexin-A (IC50 range 30-100 nM). The rank order of potency for NPY-
related peptides was hNPY > porcine peptide YY (pPYY) > (Leu(31), pro(34))
human PYY > human PYY(3-36) > hNPY free acid > human pancreatic polypeptide
. Among secretin-related peptides, the rank order of potency was porcine se
cretin greater than or equal to orexin-A > human pituitary adenylate cyclas
e-activating peptide > orexin-B > porcine vasoactive intestinal peptide. Am
ong opioid peptides, rat beta-endorphin and camel delta-endorphin were much
less active than NPY and secretin, and two enkephalins were inactive at 1
mu M. In view of high abundance of NPY in forebrain, the above cross-reacti
vity could indicate a significant contribution of NPY to signaling via orex
in-A receptors. (C) 2000 Academic Press.